flu, RSV and COVID-19
GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...
While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...
In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...
New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants Paris, . Sanofi advances its ambition to protect ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
As many as 80,000 children under 5 are hospitalized each year due to the respiratory syncytial virus, according to the CDC.
Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...